Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Residual Solvent Testing in Transdermal Patches

Posted on By

SOP for Residual Solvent Testing in Transdermal Patches

Standard Operating Procedure for Residual Solvent Testing in Transdermal Patches

1) Purpose

To establish procedures for testing residual solvents in transdermal patches to ensure compliance with safety and regulatory requirements.

2) Scope

This SOP applies to the quality control department responsible for performing residual solvent testing on transdermal patches during production.

3) Responsibilities

3.1 Quality Control Analyst: Perform residual solvent testing according to defined procedures.
3.2 Production Supervisor: Provide samples for testing in accordance with sampling plans.
3.3 QA Personnel: Review and approve testing procedures and results.
3.4 Production Operators: Assist in sample collection and preparation for testing.

See also  SOP for Packaging Line Qualification for Transdermal Patches

4) Procedure

4.1 Sample Preparation:

4.1.1 Obtain representative samples of transdermal patches from production batches.

4.1.2 Prepare samples by appropriate methods such as extraction or dilution.

4.2 Testing Method:

4.2.1 Perform residual solvent analysis using validated analytical techniques (e.g., gas chromatography).

4.2.2 Ensure testing conditions (e.g., temperature, calibration) are in accordance with method requirements.

4.3 Data Analysis:

4.3.1 Analyze test results to quantify residual solvent levels in transdermal patches.

4.3.2 Compare results against established acceptance criteria and regulatory limits.

4.4 Reporting:

4.4.1 Document testing procedures, results, and observations in designated test records or laboratory notebooks.

4.4.2 Prepare test reports summarizing residual solvent testing outcomes and compliance with specifications.

See also  SOP for Uniformity of Dosage Units in Transdermal Patches

4.5 Documentation:

4.5.1 Maintain comprehensive records of residual solvent testing activities, including raw data and calculations.

4.5.2 Archive test reports and related documentation for review and audits as per document control procedures.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QA: Quality Assurance

6) Documents, if any

Residual Solvent Testing Protocols
Test Reports
Batch Production Records

7) Reference, if any

ICH Q3C(R6): Impurities: Guideline for Residual Solvents
USP General Chapter 467: Organic Volatile Impurities

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Gel Packaging Machine
Next Post: SOP for Label Control and Accountability

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version